SparingVision Participated in the 10th Annual Biotech Showcase

World News: . []

PARIS, Jan. 12, 2018 (GLOBE NEWSWIRE) -- SparingVision, a biotechnology company focused on the discovery and development of an innovative, therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa, announced today that Florence Allouche Ghrenassia, President and Chief Executive Officer, provided a corporate overview on January 10, 2018 at the 10 Annual Biotech Showcase, held from January 8-10, 2018 at the Hilton San Francisco Union Square in San Francisco, California.

SparingVision was one of five private, French biotech companies selected out of nearly 250 companies to present at Biotech Showcase.

More news and information about SparingVision

Published By:

Globe Newswire: 15:53 GMT Friday 12th January 2018

Published: .

Search for other references to "sparingvision" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers